Hospitals FDA Clears SpinalCyte IND Application for Universal Donor Cell Therapy to Treat Lower Back Pain byJosh SandbergNovember 28, 2018
Spine Top Stories SpinalCyte Announces Positive 12 Month Pain Data From Phase 1/Phase 2 Clinical Trial for Degenerative Disc Disease byChris StewartOctober 25, 2018
Biologics SpinalCyte to Feature Fibroblast-Based Cell Therapy Results at the 2018 North American Spine Society Annual Meeting byJosh SandbergSeptember 24, 2018
Spine SpinalCyte, LLC Enrolls First Patient in Landmark Phase I Human Clinical Trial byJosh SandbergJanuary 27, 2017
